Article Listing - Winston Pharma gets orphan status for civamide

NEW PRODUCT PHASE FOR BRITISH BIO-TECH

16 March 1992

British-biotechnology Group will look back on 1991 as a milestone year in the company's history, according to chairman Brian Richards,...

ITALY'S MENARINI TO INVEST ABROAD

16 March 1992

Italian pharmaceutical concern Menarini has given up on its scheme to set up a plant on the island of Elba,...

STOCK MARKET COMMENTARY: EUROPE

16 March 1992

EUROPE: was mixed last week, with strong performance in Sweden and a poor one in Italy, where Pierrel was...

KANEBO MONOCLONAL ANTIBODIES

16 March 1992

- Japanese diversified textile and cosmetics company Kanebo Ltd plans to introduce technology for a humanized monoclonal antibody, the Smart...

GOOD GROWTH FOR RHONE-POULENC

9 March 1992

At Rhone-Poulenc, "the aggressive marketing effort on promotion-responsive products, supplemented by a roll-out of at least eight new medium-sized drugs,...

NORTH AMERICA'S OTC COUGH COLD MARKET

9 March 1992

By Mick Maroney, manager, North American Region, at Nicholas Hall & Co

The cough and cold remedies market is now established...

PHARMA OFFSETS SHARP FALL AT AKZO

9 March 1992

The Dutch chemical and pharmaceutical group, Akzo, saw declines in 1991, but buoyant pharmaceuticals helped to offset poor results in...

NEW SINO-US PHARMA VENTURE IN CHINA

9 March 1992

An agreement has been signed between the Kumming Pharma-ceutical Factory and the Ivax Corp of the USA to establish Kumming...

JAPAN URGES IL-2 AND PKU DRUG APPROVAL

9 March 1992

Japan's Central Pharmaceutical Affairs Council has urged the Public Health and Welfare Ministry to approve for manufacture and sale drugs...

NEW LAB FOR AMERSHAM

9 March 1992

Amersham International reports that it has now extended its contract service for the preparation of radio-labelled biomedical molecules with the...